In this study, we demonstrated the combined use of EpCAM and FRα as capture targets in NSCLC cell lines and NSCLC patients with higher efficacy and sensitivity, suggesting their translational potential for future development of CTC detection methods. Here, EPCAM is linked to non-small cell lung carcinoma.